[Skip to Navigation]
Sign In
Views 185
Citations 0
Comment & Response
July 8, 2021

Reporting the Analytical Method Is Essential to Assessing Studies in Which Biomarkers Are a Major Study Objective—Reply

Author Affiliations
  • 1Breast Unit, Kliniken Essen-Mitte, Essen, Germany
  • 2Amedes MVZ Wagnerstibbe für Laboratoriumsmedizin, medizinische Mikrobiologie und Immunologie, Göttingen, Germany
  • 3German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
JAMA Oncol. 2021;7(9):1403-1404. doi:10.1001/jamaoncol.2021.2046

In Reply We appreciate the comments from van Rossum et al in response to our recent randomized clinical trial on the efficacy of endocrine therapy for treatment of breast cancer in men.1 We investigated the extent of estradiol change in male patients with breast cancer receiving different kinds of endocrine therapies (tamoxifen, tamoxifen plus gonadotropin-releasing hormone analogue [GnRHa] or exemestane plus GnRHa) as the primary objective. Secondary objectives were changes in other sexual hormone parameters, libido, and quality of life, as well as adverse effects.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words